Diagram of patients enrolled. MRD‐directed DLI was the first choice for patients in the high‐level MRD group, and those who could not receive DLI because of patient refusal (n = 15) or provider refusal (n = 2) received interferon‐α treatment.
Abbreviations: DLI, donor lymphocyte infusion; MRD, minimal residual disease.